Please Share::
�� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��
��
-->
��
MACQUARIE ON COAL INDIA : ET NOW
Upgrage to Outperform from Neutral
Target for Coal India at `310 , Implying 21% upside
Supply tightness makes risk-reward favourable
Low coal inventory to keep volumes elevated in H218
EPS to grow after five years
Expect 100% dividend payout in FY18
MACQUARIE ON GODREJ CONSUMER : ET NOW
Maintain Outperform , Target at `1159/share
Stock trades at 10% discount to sector
GCPL is top pick in India Consumer Sector
CREDIT SUISSE ON LUPIN : ET NOW
Maintian Neutral , Target 850/share
Target cut from `850 to `875/share
Negative surprise seen from Fortamet
Cut our FY18-20E EPS by 3%
Fortamet still an important product for Lupin
CREDIT SUISSE ON NESLTE : ET NOW
Maintain Outperfrom , Target at `8700/share
Concerns on infant nutrition category misplaced
See high growth headroom in India
CLSA ON ZEE : ET NOW
Maintain BUY , Target at `707 from 660/share
20% EPS CAGR to drive price
Recovery in advertising spends a positive
Stock trading at its three-year average PE
Infant nutrition is a growing category in India.
CLSA ON RIL : ET NOW
Maintain BUY , Target 1080
JioPhone to drive next leg of growth
Ramp-up of JioPhone is a trigger in coming months
Expect EBITDA to be driving by Telecom biz
CLSA ON MIDCAP IT : ET NOW
Most Midcap it declared strong Q2 results
The 10 midcap IT firms are up 25% YTD
Midcaps now trade at 15x CY18
Prefer L&T Tech & Persistent among midcaps
GOLDMAN ON INDIA PHARMA : ET NOW
Maintain BUY on Aurobindo & Sun ;Sell Cipla
Revise US base Biz pricing erosion est 12% from 10%
US business to remain a sore thumb
Volume share gains to offset price decline
Margins remain significantly higher than US peers
No comments:
Post a Comment